Andre-Jacques Auberton-Herve - Director at Bionik Laboratories Corp.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Andre-Jacques Auberton-Herve since 13 Sep 2025

Reported holdings for Andre-Jacques Auberton-Herve in Bionik Laboratories Corp.

Form 4 holding Director

Bionik Laboratories Corp.

Security class
Common Stock
Shares / value
1,109,271
Estimated value
$665,563
Report date
13 Jun 2023
Price
$0.6000
Ownership
Shares held through Star SCI
Form 4 holding Director

Bionik Laboratories Corp.

Security class
Common Stock
Shares / value
95,149
Estimated value
$57,089
Report date
13 Jun 2023
Price
$0.6000
Ownership
Direct
Form 4 holding Director

Bionik Laboratories Corp.

Security class
Common Stock
Shares / value
10,693
Estimated value
$6,416
Report date
13 Jun 2023
Price
$0.6000
Ownership
Shares held through 4A Consulting and Engineering
Form 4 holding Director

Bionik Laboratories Corp.

Security class
Convertible Promissory Note
Shares / value
1
Estimated value
Report date
13 Jun 2023
Price
Ownership
Through Star SCI
Underlying class
Common Stock, par value $0.001 per share
Underlying amount

Transaction history for Andre-Jacques Auberton-Herve in Bionik Laboratories Corp.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .